BRPI0715182B8 - uso de um composto - Google Patents

uso de um composto

Info

Publication number
BRPI0715182B8
BRPI0715182B8 BRPI0715182A BRPI0715182A BRPI0715182B8 BR PI0715182 B8 BRPI0715182 B8 BR PI0715182B8 BR PI0715182 A BRPI0715182 A BR PI0715182A BR PI0715182 A BRPI0715182 A BR PI0715182A BR PI0715182 B8 BRPI0715182 B8 BR PI0715182B8
Authority
BR
Brazil
Prior art keywords
perineum
vagina
tissues
risk
mixing
Prior art date
Application number
BRPI0715182A
Other languages
English (en)
Inventor
Mura Emanuela
Mailland Federico
Mascarucci Paolo
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of BRPI0715182A2 publication Critical patent/BRPI0715182A2/pt
Publication of BRPI0715182B1 publication Critical patent/BRPI0715182B1/pt
Publication of BRPI0715182B8 publication Critical patent/BRPI0715182B8/pt
Publication of BRPI0715182C1 publication Critical patent/BRPI0715182C1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

uso de um composto composições para melhorar a elasticidade da vagina e do períneo durante o último trimestre de gravidez, incluem a combinação de um composto tiolado ou mistura do mesmo com um éster de ácido orgânico ou mistura do mesmo. as composições de acordo com a presente invenção melhoram as propriedades elásticas dos tecidos da vagina e/ou do períneo em termos de ambos, extensibilidade aumentada e recuperação elástica mais rápida. as composições de acordo com a presente invenção podem diminuir o risco de trauma dos tecidos do períneo, assim como o risco de incontinência retal ou urinária como uma complicação pós-parto a pequeno/médio/longo prazo.
BRPI0715182A 2006-08-09 2007-04-18 uso de um composto BRPI0715182C1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06118649.0 2006-08-09
EP20060118649 EP1886676A1 (en) 2006-08-09 2006-08-09 Compositions with enhanced elasticizing activity
PCT/EP2007/053793 WO2008017521A2 (en) 2006-08-09 2007-04-18 Compositions with enhanced elasticizing activity

Publications (4)

Publication Number Publication Date
BRPI0715182A2 BRPI0715182A2 (pt) 2012-12-25
BRPI0715182B1 BRPI0715182B1 (pt) 2020-07-28
BRPI0715182B8 true BRPI0715182B8 (pt) 2020-08-11
BRPI0715182C1 BRPI0715182C1 (pt) 2021-05-25

Family

ID=37575000

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0715182A BRPI0715182C1 (pt) 2006-08-09 2007-04-18 uso de um composto

Country Status (23)

Country Link
US (1) US9125806B2 (pt)
EP (2) EP1886676A1 (pt)
JP (2) JP2010500309A (pt)
KR (2) KR101521166B1 (pt)
CN (1) CN101500550B (pt)
AR (1) AR062304A1 (pt)
AT (1) ATE457723T1 (pt)
BR (1) BRPI0715182C1 (pt)
CA (1) CA2655472C (pt)
CY (1) CY1110032T1 (pt)
DE (1) DE602007004857D1 (pt)
DK (1) DK2049092T3 (pt)
EA (1) EA014971B1 (pt)
ES (1) ES2340335T3 (pt)
HK (1) HK1126956A1 (pt)
HR (1) HRP20100212T1 (pt)
MX (1) MX2009000869A (pt)
NO (1) NO343143B1 (pt)
PL (1) PL2049092T3 (pt)
PT (1) PT2049092E (pt)
RS (1) RS51282B (pt)
SI (1) SI2049092T1 (pt)
WO (1) WO2008017521A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3081212A1 (en) 2015-04-16 2016-10-19 Polichem SA Carboxymethylcysteine for topical treatment of stretch marks
EP3442501A1 (en) 2016-04-15 2019-02-20 Fairhaven Health, LLC Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract
IT202100002285A1 (it) * 2021-02-03 2022-08-03 Farm Dott Ferretti Stefano Nuova composizione

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617639A1 (de) * 1966-09-12 1972-04-20 Mini Ind Chimice Verfahren zur Herstellung eines Arzneimittels zur Behandlung von physiologischen Hautkrankheiten
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use
GB9213472D0 (en) * 1992-06-25 1992-08-12 Unilever Plc Cosmetic composition
WO1995034280A1 (en) * 1994-06-15 1995-12-21 The Procter & Gamble Company Methods of lightening hyperpigmented regions in mammalian skin
JP3542665B2 (ja) * 1995-07-07 2004-07-14 株式会社資生堂 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤
FR2740340B1 (fr) * 1995-10-30 1997-12-05 Oreal Utilisation d'acides carboxyliques porteurs d'une fonction soufree pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
US20050266064A1 (en) * 2004-05-29 2005-12-01 Mccarthy Kathryn J Cosmetic compositions and methods
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
US7087560B2 (en) * 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
BRPI0515846B1 (pt) * 2004-10-25 2020-10-20 Unilever N.V composição de higiene pessoal
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin

Also Published As

Publication number Publication date
BRPI0715182A2 (pt) 2012-12-25
HRP20100212T1 (hr) 2010-05-31
ATE457723T1 (de) 2010-03-15
NO20091011L (no) 2009-03-06
EA014971B1 (ru) 2011-04-29
EP2049092A2 (en) 2009-04-22
CY1110032T1 (el) 2015-01-14
SI2049092T1 (sl) 2010-04-30
DE602007004857D1 (de) 2010-04-01
HK1126956A1 (en) 2009-09-18
KR20090050065A (ko) 2009-05-19
JP2010500309A (ja) 2010-01-07
WO2008017521A3 (en) 2008-05-22
CN101500550A (zh) 2009-08-05
NO343143B1 (no) 2018-11-19
CA2655472C (en) 2014-10-21
PT2049092E (pt) 2010-04-21
JP5771649B2 (ja) 2015-09-02
EP2049092B1 (en) 2010-02-17
US20090291931A1 (en) 2009-11-26
CN101500550B (zh) 2011-12-14
JP2013227334A (ja) 2013-11-07
BRPI0715182B1 (pt) 2020-07-28
KR101521166B1 (ko) 2015-05-19
PL2049092T3 (pl) 2010-07-30
EA200900293A1 (ru) 2009-06-30
AR062304A1 (es) 2008-10-29
RS51282B (sr) 2010-12-31
WO2008017521A2 (en) 2008-02-14
EP1886676A1 (en) 2008-02-13
KR20140046080A (ko) 2014-04-17
CA2655472A1 (en) 2008-02-14
MX2009000869A (es) 2009-02-04
BRPI0715182C1 (pt) 2021-05-25
ES2340335T3 (es) 2010-06-01
DK2049092T3 (da) 2010-05-10
US9125806B2 (en) 2015-09-08

Similar Documents

Publication Publication Date Title
AU2016204344A1 (en) Improved methods and compositions for wound healing
MEP88208A (en) Leptomycin derivatives
RS51185B (sr) Kompozicije za vaginalnu primenu
BR112012010539A2 (pt) método de economia de energia, sistema de economia de energia e estação base
BRPI0801858A2 (pt) uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica
BRPI0922355A8 (pt) Ácidos nucléicos, métodos para reduzir a expressão de um gene em uma célula in vitro, uso do ácido nucléico, complexo de rna e uso do complexo de rna
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
PL1723104T3 (pl) Kompozycje zawierające siarkę i sposoby ich wytwarzania
BR112012012476A2 (pt) "composições nutritivas incluindo um componente de alta proteína e nucleotídeos exôgenos"
BR112012011951A2 (pt) composição adesiva para tecidos moles, composição adesiva para curativo ou composição curativa
BR112013007446A2 (pt) afastador minimamente obstrutivo
BRPI0907559B8 (pt) pessário vaginal com tamanho e formato apropriados para o alívio de prolapso de órgão e sistema de pessário
CL2008001756A1 (es) Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac)
AR064301A1 (es) Absorbente de fosfato basado en hierro (iii)
AR052030A1 (es) Nueva composicion para facilitar el parto humano
BR112012033295A2 (pt) polipeptídeos curtos e contendo d-aminoácido para conjugados terapêuticos e seu uso
MY153981A (en) Blends of polyarylene ethers and polyarylene sulfides comprising carboxylic anhydrides
BR112014015306A8 (pt) dispositivo de inserção vaginal com segmentos perpendiculares
BRPI0715182B8 (pt) uso de um composto
BR112012012960A2 (pt) supositório para administração retal, vaginal ou uretral e seus usos.
ECSP099483A (es) Combinación de un inhibidor de desacetilasa de histona y un antimetabolito
AR060195A1 (es) Agentes, composiciones y metodos para aclarar la piel
BR112012015682A2 (pt) composição transportadora.
BR112015004220A2 (pt) composições para o tratamento de psoríase
ECSP088242A (es) Combinaciones que comprenden dmxaa para el tratamiento de cancer

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/02/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16D Grant of patent or certificate of addition of invention cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 16.1 NA RPI NO 2562 DE 11/02/2020 POR TER SIDO INDEVIDA.

B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2586 DE 28/07/2020 QUANTO AO RELATORIO DESCRITIVO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/04/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF